Egg hypersensitivity in review
Abstract:Egg hypersensitivity is the second most common food allergy with a prevalence of up to 1.7% and the discovery of information about egg allergy is ongoing. This review aims to summarize the current understanding of the allergens involved, natural history, clinical presentation, diagnostic strategies, treatment options, egg-containing vaccine guidelines, and future therapies for health care providers in managing egg hypersensitivity. Recent clinically applicable articles are reviewed for the allergist as an update for the state of the art management of egg allergy. Approximately 70% of children will outgrow egg allergy by 16 years of age and children are able to tolerate well-cooked eggs sooner than uncooked eggs. Egg-specific IgE of >50 kIUA/L can be used as a predictor for persistent egg allergy. Double-blind placebo-controlled food challenges are still the gold standard for diagnosis. Oral immunotherapy trials still are not generalizable for routine clinical practice, but the influenza vaccine can be given to most egg-allergic patients. Allergists can now educate, diagnose, and manage egg-allergic patients with state-of-the-art information to improve patient's quality of life as never before.
Document Type: Research Article
Affiliations: Department of Internal Medicine and Pediatrics, University of Texas Health Science Center at Houston, Houston, Texas, USA
Publication date: January 1, 2013
More about this publication?
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- Ingenta Connect is not responsible for the content or availability of external websites